| pubmed-article:9290 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9290 | lifeskim:mentions | umls-concept:C0040046 | lld:lifeskim |
| pubmed-article:9290 | lifeskim:mentions | umls-concept:C0017725 | lld:lifeskim |
| pubmed-article:9290 | lifeskim:mentions | umls-concept:C0574032 | lld:lifeskim |
| pubmed-article:9290 | lifeskim:mentions | umls-concept:C0037633 | lld:lifeskim |
| pubmed-article:9290 | lifeskim:mentions | umls-concept:C1517004 | lld:lifeskim |
| pubmed-article:9290 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:9290 | pubmed:dateCreated | 1976-11-21 | lld:pubmed |
| pubmed-article:9290 | pubmed:abstractText | An experimental method is presented, which compares the tendency of different infusions to cause thrombophlebitis. It is based ona quantitative histological analysis of the inflammatory changes in the veins of rabbit ears after infusions under standardized conditions. By means of this method the inflammatory changes in the veins have been shown to be significantly less pronounced when the pH of glucose solutions is altered from 3.0 to 3.6. This pH change has been prescribed in the 1971 corrections to Pharmacopoea Nordica 1963. By complete neutralization of 5% glucose a further reduction of the damage to the veins has been obtained. For this purpose phosphate buffer is recommended. | lld:pubmed |
| pubmed-article:9290 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9290 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9290 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9290 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9290 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9290 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9290 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:9290 | pubmed:issn | 0340-0964 | lld:pubmed |
| pubmed-article:9290 | pubmed:author | pubmed-author:HessovII | lld:pubmed |
| pubmed-article:9290 | pubmed:author | pubmed-author:Bojsen-Møller... | lld:pubmed |
| pubmed-article:9290 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9290 | pubmed:volume | 2 | lld:pubmed |
| pubmed-article:9290 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9290 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9290 | pubmed:pagination | 97-101 | lld:pubmed |
| pubmed-article:9290 | pubmed:dateRevised | 2009-11-16 | lld:pubmed |
| pubmed-article:9290 | pubmed:meshHeading | pubmed-meshheading:9290-Ani... | lld:pubmed |
| pubmed-article:9290 | pubmed:meshHeading | pubmed-meshheading:9290-Glu... | lld:pubmed |
| pubmed-article:9290 | pubmed:meshHeading | pubmed-meshheading:9290-Ear | lld:pubmed |
| pubmed-article:9290 | pubmed:meshHeading | pubmed-meshheading:9290-Thr... | lld:pubmed |
| pubmed-article:9290 | pubmed:meshHeading | pubmed-meshheading:9290-Hyd... | lld:pubmed |
| pubmed-article:9290 | pubmed:meshHeading | pubmed-meshheading:9290-Vei... | lld:pubmed |
| pubmed-article:9290 | pubmed:meshHeading | pubmed-meshheading:9290-Rab... | lld:pubmed |
| pubmed-article:9290 | pubmed:meshHeading | pubmed-meshheading:9290-Sol... | lld:pubmed |
| pubmed-article:9290 | pubmed:meshHeading | pubmed-meshheading:9290-Inf... | lld:pubmed |
| pubmed-article:9290 | pubmed:year | 1976 | lld:pubmed |
| pubmed-article:9290 | pubmed:articleTitle | Experimental infusion thrombophlebitis. Importance of the pH of glucose solutions. | lld:pubmed |
| pubmed-article:9290 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9290 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9290 | lld:pubmed |
